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Background: Rare copy number variations (CNVs) are today recognized as an important cause of various
neurodevelopmental disorders, including mental retardation and epilepsy. In some cases, a second CNV may
contribute to a more severe clinical presentation.
Results: Here we describe a patient with epilepsy, mental retardation, developmental disorders, and dysmorphic
features, who inherited a deletion of 16p13.11 and a triplication of 19p13.3 from his father and mother, respectively.
The mother presented mild mental retardation and language delay too.
Conclusions: We discuss the phenotypic consequences of the two CNVs and suggest that their synergistic effect is
likely responsible for the complicated clinical features observed in our patient.
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Rare copy number variations (CNVs) are today recog-
nized as important genetic causes or risk factors for
intellectual disability (ID), autism, schizophrenia, and
epilepsy.
Recurrent deletions and duplications are important
contributors to neurodevelopmental disorders with
complex inheritance, including epilepsy. Among them,
16p13.11 deletion was described in individuals with
schizophrenia [1], autism [2], epilepsy [3-5], attention
deficit hyperactivity disorders [6], intellectual disability,
microcephaly, and/or multiple congenital anomalies
[2,7]. The variety of phenotypes and the presence of the
rearrangement in unaffected relatives may be due to sev-
eral factors, such as incomplete penetrance, variable* Correspondence: eli.tassano@gmail.com
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unless otherwise stated.expressivity, and failure to recognize subtle manifesta-
tions, imprinting, and environmental factors.
In a number of patients, the phenotypic differences
could be due to a second CNV, as reported in a study
on 2312 children known to carry a CNV associated with
intellectual disability and congenital abnormalities [8].
Furthermore, this study revealed that the secondary
CNVs are preferentially transmitted from maternal
carriers.
Interstitial duplications, and even more triplications,
of the short arm of chromosome 19 are very rare. To
our knowledge, only four patients have been described
with a pure interstitial duplication of 19p ranging from
the locus 19p13.2 to 19p13.3 and presenting various
phenotypic features [9-12].
We describe here, for the first time, clinical observa-
tions and array-CGH analysis of a patient with concomi-
tant occurrence of a deletion of chromosome 16p13.11
and a triplication of chromosome 19p13.3.l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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The patient is a 13-year-old Italian male born to non-
consanguineous parents with no other siblings. The
mother presented with mild mental retardation and lan-
guage delay. The father had a sternal malformation de-
scribed as pectus excavatum and his language was poor.
The infant was delivered at 37 weeks of gestation by
caesarean section due to polyhydramnios after an un-
eventful pregnancy. At birth, his weight, length, and
occipitofrontal circumference (OFC) were normal (>50th
centile). He presented a dermoid cyst in his left eyebrow
and bilateral clubfoot. Since the first years of life, he
showed psychomotor development and language delay.
CT scan and brain MRI showed an arachnoid cyst on
the right side in the middle cranial fossa associated with
temporo-mesial hypoplasia. An expansion of the cyst
reached the paraclinoid region. Until the age of 7 years
he was fed with liquid food because of difficulties in
swallowing and chewing solid foods. Control of the
sphincters was achieved at 7 years of age.
At 13 years of age, he was admitted to our hospital for
seizure in apyrexia. His stature and OFC were normal.
He had dysmorphic features like a long coarse face, flat
occiput, brachycephaly, hypertelorism, shortened palpe-
bral fissures, broad nasal bridge, short nose, long phil-
trum, prominent everted lower lips, open mouth, low set
ears, maxillary hypoplasia, brachydactyly, and talipes
equinovarus (Figure 1). Moreover, he had a developmen-
tal disorder characterized by poor speech and language
delay. Neuropsychiatric evaluation showed intellectual
disability with hyperactive and aggressive behaviour.
Eye examination and fundoscopy revealed a right optic
papilla with normal macula and the presence of tissueFigure 1 Patient at the age of 13 years old. Note long coarse face, flat o
broad nasal bridge and short nose, long philtrum, full prominent everted looedema at the upper pole. EEG showed an abnormal
generalized non-specific pattern, right epileptiform ab-
normal pattern waveform with spikes and spike and
waves discharges.
Results
Cytogenetic analysis, performed on GTG-banded meta-
phases from cultured lymphocytes of the patient and
his parents, showed normal karyotypes. Considering the
phenotypic abnormalities of the patient, array-CGH
analysis was performed, revealing two CNVs. The first
was a 1.323 Mb interstitial deletion at 16p13.11 spanning
from probe A_16_P40566850 (14,968,855 bps) to probe
A_16_P03120838 (16,292,235 bps), inherited from the
father; the deleted region was flanked by low copy re-
peats (LCR16s). The second was a triplication of 625.8Kb
at 19p13.3 spanning from probe A_16_P20946356
(5,016,071 bps) to probe A_14_P124343 (5,641,847 bps),
inherited from the mother (Figure 2A-B) [arr 16p13.11
(14,968,855-16,292,235)×1 pat, 19p13.3(5,016,071-5,641,847)×4
mat]. Array-CGH of maternal grandmother and mater-
nal aunt were normal. FISH analysis confirmed the du-
plication on 19p13.3 of the proband and his mother
excluding any insertion or translocation.
The 16p13.3 deleted region contains nine OMIM
genes: NOMO1 (MIM 609157) nodal modulator 1;
PDXDC1 (MIM 614244) pyridoxal-dependent decarb-
oxylase domain-containing protein 1; NTAN1 (MIM
615367) n-terminal asparagine amidase; RRN3 (MIM
605121) RRN3, s. cerevisiae, homolog; KIAA0430 (MIM
614593) KIAA0430 gene; NDE1 (MIM 609449) Nude,
homolog of A. nidulans; MYH11 (MIM 160745) myosin,
heavy chain 11, smooth muscle; ABCC1 (MIM 158343)cciput, brachycephaly, hypertelorism, shortened palpebral fissures,
wer lips, open mouth, low set ears, maxillary hypoplasia.
Figure 2 Results of array-CGH analysis. A) Array-CGH analysis shows a 1.323 Mb interstitial deletion at 16p13.3 band spanning from probe
A_16_P40566850 (14,968,855 bps) to probe A_16_P03120838 (16,292,235 bps) inherited from the father. B) Array-CGH analysis shows a a triplication of
625.8Kb at 19p13.3 band spanning from probe A_16_P20946356 (5,016,071 bps) to probe A_14_P124343 (5,641,847 bps), inherited from his mother.
C) Overview of the region 16p13.11 and its gene contents, according to the UCSC Genome Browser (GRCh37/hg19 assembly). The circles indicate the
genes, which could be responsible for the phenotypic features of the 16p13.11 deletion patients. The deleted region was flanked by low copy repeats
(LCR16s). D) Overview of the region 19p13.3 and its gene contents, according to the UCSC Genome Browser (GRCh37/hg19 assembly). The circles
indicate the genes, which could be responsible for the phenotypic features of the patient with the 19p13.3 triplication.
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(MIM 603234) ATP-binding cassette, subfamily c, member
6. This region also contains twelve micro RNA (Figure 2C).
The trisomic region of chromosome 19 harbours six
OMIM genes: KDM4B (MIM 609765) lysine-specific
demethylase 4B; PTPRS (MIM 601576) protein-tyrosine
phosphatase, receptor-type, sigma; ZNRF4 (MIM 612063)
zinc finger and ring finger protein 4; TINCR (MIM 615241)
terminal differentiation-induced noncoding RNA; SAFB2
(MIM 608066) scaffold attachment factor b2; SAFB1 (MIM
602895) scaffold attachment factor b (Figure 2D).
Discussion
We describe a boy with a paternally inherited interstitial
deletion at 16p13.11 band and a concomitant partialinterstitial triplication of 19p13.3 inherited from his mother.
Essentially, the boy presented cerebral, skeletal, neurological
anomalies, and facial dysmorphisms. Furthermore, he had
intellectual disability with severe speech and language delay
associated with hyperactive and aggressive behaviour.
Although genomic imbalances involving 16p13.11 have
already been reported in the literature, this is the first re-
ported patient carrying a 16p13.11 microdeletion and a
concomitant 19p13.3 triplication.
The recurrent 16p13.11 microdeletion spans about
1.65 Mb encompassing 15 RefSeq genes. Breakpoints of
the deletion are located in two LCR blocks (LCR16s),
which implies that non-allelic homologous recombination
(NAHR) between these flanking LCRs may mediate this
rearrangements.
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strongest candidates for the neurodevelopmental pheno-
types that we identified are NDE1 and NTAN1, whose
inactivation was reported as associated with abnormal
neurological features [13-15].
The 16p13.11 microdeletion is associated with neuro-
developmental phenotypes such as autism, intellectual
disability, epilepsy, and learning difficulties, and with
non-CNS phenotypes such as physical dysmorphisms
and congenital anomalies [1-5,7]. Recently, evidence of a
male-biased autosomal effect has emerged; males with
the microdeletion are more likely to manifest symptoms
[16]. This microdeletion has also been found in normal
individuals. The presence of this rearrangement in un-
affected relatives may be due to a number of factors,
such as incomplete penetrance, variable expressivity, or
imprinting [17].
Our patient also carried a 625.8Kb interstitial triplica-
tion at 19p13.3 band. Triplications are rare chromo-
somal aberrations and are sometimes observed as the
consequence of non-allelic homologous recombination
[18]. Triplications of the short arm of chromosome 19
have never been reported.
The phenotype of our patient is comparable with that
reported in other patients with a16p13.11 deletion, how-
ever our patient has more severe features such as brain
abnormalities, brachycephaly, and bilateral talipes equi-
novarus. Also his neurological features seem to be more
complicated than those previously reported in the
literature.
Regarding 19p13.3 triplication, it is difficult to deter-
mine its effect on the phenotype of our patient. To our
knowledge, there are no reported cases of triplications in
literature and only few cases of duplications.
Ishikawa et al., [19] reported on four patients with
constitutional interstitial 19p13.3 duplication, none of
them overlapping our case. In the Decipher database,
there are no patients with duplications encompassing
the same region as that reported here, though there are
three patients affected by intellectual disability with
smaller, partially overlapping duplications (cases 258703,
271079, 253689).
Interestingly, our patient inherited the triplication
from his mother, who presented mild intellectual disabil-
ity and language delay. Among the genes included in the
triplicated region, two genes, SAFB1 and SAFB2, are prob-
ably of interest; they function as oestrogen receptor co-
repressors, and their overexpression results in inhibition
of proliferation also in the central nervous system [20].
Another interesting gene is PTPRS, which is expressed
selectively and at high levels in the central and periph-
eral nervous systems during neural development. Its
product plays a role in neuronal survival, synaptic plasti-
city, axon guidance, and nerve regeneration [21-23].Furthermore, studies in chickens showed that overex-
pression of PTPRS in primary sensory neurons inhibits
neurite outgrowth [24].
Conclusions
In conclusion, we report on a boy with a combination of
16p13.11 microdeletion and a 19p13.3 triplication. The
synergistic effect of the two genomic imbalances is pos-
sibly responsible for the complicated clinical features ob-
served in our patient and hopefully our case will help us
better understand the relative contributions to the
phenotype of different chromosome imbalances and will
enable us to provide better genetic counselling in the fu-
ture. However, we cannot exclude that the patient’s
phenotype could also be the result of a mutation in a
specific gene.
Methods
Standard GTG banding was performed at a resolution of
400–550 bands on metaphase chromosomes from per-
ipheral blood lymphocytes of the patient and his parents.
Molecular karyotyping was performed on the patient, his
parents, maternal grandmother and maternal aunt using
Human Genome CGH Microarray Kit G3 180 (Agilent
Technologies, Palo Alto, USA) with ~13Kb overall median
probe spacing. Labelling and hybridization were per-
formed following the protocols provided by the manu-
facturers. A graphical overview was obtained using the
Agilent Genomic Workbench Lite Edition Software
6.5.0.18. FISH was performed using Agilent Custom FISH
19p13.3 spanning 626Kb (chr19:5,015,926-5,641,995)
(Green) (Agilent Technologies, Palo Alto, USA) and
subtelomeric probe 19q (Orange) (Cytocell Aquarius,
Cambridge, UK).
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